@becleartoday Thanks for sharing. I was surprised with the recommendation that patients on brensocatib not be on atorvastatin long term. I've read atorvastatin is thought to have anti-inflammatory properties and small studies showed benefits of atorvastatin in bronchiectasis for that reason. Do you have insight on this issue? Are some patients taking it for just bronchiectasis and panel wants to discourage that? It doesn't sound like it works thru same pathway, therefore it doesn't seem it would increase toxicity. Are they recommending patients on it for cardiac issues stop? It's ok if we just need to wait for release of recs. I'm just curious.